GLOBAL DEAL SYNDICATION
HBS Alumni Angels syndicates selected deals across the full global membership of its 14 chapters. This enables selected deals from one chapter to reach a global network of accredited investor alumni. This is a unique benefit of being a member in a local HBS Alumni Angel chapter. Investment decisions are made and executed individually following a global webinar. Once investments are made, investors often assist companies in other areas as formal or informal advisers. For details on how the process works, please scroll down.
UPCOMING SYNDICATION CALLS
GLOBAL SYNDICATED INVESTMENT PRESENTATION:
New View Surgical
August 26, 2020 I 8am PDT, 11 am EDT, 4pm London, 5pm Continental Europe
Presenters: Bryce Klontz, President & CEO of New View Surgical and
Elaine Gilde, MBA'78, HBSAA New York
About this event:
On behalf of the New York chapter, we would like to share the following investment opportunity:
New View Surgical, Inc. is a Boston-based med-tech firm that has developed a disruptive surgical visualization system for minimally invasive surgical procedures. The company’s mission is to increase patient access to minimally invasive surgical techniques world-wide. New View Surgical’s innovative and IP-protected VisionPort System simplifies minimally invasive procedures and addresses multiple pain points and inefficiencies that have persisted in minimally invasive surgery for years. Additionally, the system’s simplified design reduces the large capital equipment footprint and significant costs long associated with MIS visualization systems. New View Surgical’s team of executives, each with 25+ years of med tech experience, has completed the development of our first generation system and it preparing for submission to the FDA for 510(k) clearance by the end of 2020.
New View Surgical is currently raising $2M through a Series A-1 preferred equity offering. The Series A-1 round, initiated in June 2020, is already 75% full with investments from members of New York Angels (lead), Mid-Atlantic Bio-Angels, Harvard Business School Alumni Angels – New York, Keiretsu Forum, Ariel Savannah Angel Partners, among others. A majority of the Series A-1 funds have come via follow-on investments from current investors. The company plans to use the Series A-1 funds for operations through FDA clearance, transfer to manufacturing activities and to execute a thoughtful pre-commercialization market research and customer-engagement plan to strengthen their US product launch strategy and to increase the likelihood of short-term interest from strategic acquirers.
PAST SYNDICATED COMPANIES
HOW IT WORKS
Use arrows on the side to navigate
Ideally, for global syndication a company should meet the following requirements:
Local host chapter members committed to invest at least $50,000* and local chapter forwards deal to global for syndication;
Company assures at least $50,000-100,000 investible capacity;
Company provides at least 2 weeks for due diligence following the webinar, prior to requiring an investment decision;
Minimum individual investment amount is set at $25,000 or less;
The Global Syndication Committee selects the most suitable company candidates from the 15 participating HBSAA chapters and is aiming to host monthly webinars.
*NY and other larger chapters may have a $100,000 min.